Ben Zekry Sagit, Sreedharan Subhashaan, Han Donghee, Sellers Stephanie, Ahmadi Amir A, Blanke Philipp, Hadamitzky Martin, Kim Yong-Jin, Conte Edoardo, Andreini Daniele, Pontone Gianluca, Budoff Matthew J, Gottlieb Ilan, Lee Byoung Kwon, Chun Eun Ju, Cademartiri Filippo, Maffei Erica, Marques Hugo, Shin Sanghoon, Choi Jung Hyun, Virmani Renu, Samady Habib, Stone Peter H, Berman Daniel S, Narula Jagat, Shaw Leslee J, Bax Jeroen J, Leipsic Jonathon, Chang Hyuk-Jae
Department of Radiology, St. Paul's Hospital and University of British Columbia, Vancouver, BC, Canada.
Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
J Cardiovasc Comput Tomogr. 2022 May-Jun;16(3):222-229. doi: 10.1016/j.jcct.2021.09.012. Epub 2021 Oct 14.
To investigate potential differences in plaque progression (PP) between in East Asians and Caucasians as well as to determine clinical predictors of PP in East Asians.
Studies have demonstrated differences in cardiovascular risk factors as well as plaque burden and progression across different ethnic groups.
The study comprised 955 East Asians (age 60.4 ± 9.3 years, 50.9% males) and 279 Caucasians (age 60.4 ± 8.6 years, 74.5% males) who underwent two serial coronary computed tomography angiography (CCTA) studies over a period of at least 24 months. Patients were enrolled and analyzed from the PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging) registry. After propensity-score matching, plaque composition and progression were compared between East Asian and Caucasian patients. Within East Asians, the plaque progression group (defined as plaque volume at follow-up CCTA minus plaque volume at baseline CCTA> 0) was compared to the no PP group to determine clinical predictors for PP in East Asians.
In the matched cohort, baseline volumes of total plaque as well as all plaque subtypes were comparable. There was a trend towards increased annualized plaque progression among East Asians compared to Caucasians (18.3 ± 24.7 mm/year vs 16.6 mm/year, p = 0.054). Among East Asians, 736 (77%) had PP. East Asians with PP had more clinical risk factors and higher plaque burden at baseline (normalized total plaque volume of144.9 ± 233.3 mm vs 36.6 ± 84.2 mm for PP and no PP, respectively, p < 0.001). Multivariate logistic regression analysis showed that baseline normalized plaque volume (OR: 1.10, CI: 1.10-1.30, p < 0.001), age (OR: 1.02, CI: 1.00-1.04, p = 0.023) and body mass index (OR: 2.24, CI: 1.01-1.13, p = 0.024) were all predictors of PP in East Asians. Clinical events, driven mainly by percutaneous coronary intervention, were higher among the PP group with a total of 124 (16.8%) events compared to 22 (10.0%) in the no PP group (p = 0.014).
East Asians and Caucasians had comparable plaque composition and progression. Among East Asians, the PP group had a higher baseline plaque burden which was associated with greater PP and increased clinical events.
研究东亚人和高加索人在斑块进展(PP)方面的潜在差异,并确定东亚人PP的临床预测因素。
研究表明,不同种族在心血管危险因素、斑块负荷和进展方面存在差异。
该研究纳入了955名东亚人(年龄60.4±9.3岁,50.9%为男性)和279名高加索人(年龄60.4±8.6岁,74.5%为男性),他们在至少24个月的时间里接受了两次连续的冠状动脉计算机断层扫描血管造影(CCTA)检查。患者来自PARADIGM(通过计算机断层扫描血管造影成像确定动脉粥样硬化斑块进展)登记处并进行分析。在倾向得分匹配后,比较东亚和高加索患者的斑块成分和进展情况。在东亚人中,将斑块进展组(定义为随访CCTA时的斑块体积减去基线CCTA时的斑块体积>0)与无PP组进行比较,以确定东亚人PP的临床预测因素。
在匹配队列中,总斑块以及所有斑块亚型的基线体积相当。与高加索人相比,东亚人的年化斑块进展有增加的趋势(18.3±24.7mm/年 vs 16.6mm/年,p = 0.054)。在东亚人中,736人(77%)有PP。有PP的东亚人在基线时有更多的临床危险因素和更高的斑块负荷(PP组和无PP组的标准化总斑块体积分别为144.9±233.3mm和36.6±84.2mm,p < 0.001)。多因素逻辑回归分析显示,基线标准化斑块体积(OR:1.10,CI:1.10 - 1.30,p < 0.001)、年龄(OR:1.02,CI:1.00 - 1.04,p = 0.023)和体重指数(OR:2.24,CI:1.01 - 1.13,p = 0.024)均为东亚人PP的预测因素。主要由经皮冠状动脉介入治疗驱动的临床事件在PP组中更高,共有124例(16.8%)事件,而无PP组为22例(10.0%)(p = 0.014)。
东亚人和高加索人的斑块成分和进展相当。在东亚人中,PP组的基线斑块负荷更高,这与更大的PP和更多的临床事件相关。